How cancer becomes drug-resistant, find researchers

A team of researchers, including an Indian-American scientist, has found that the major reason cancer drugs fail is that they cannot penetrate the high-pressure environment of solid tumours.

IANS May 11, 2016 17:11:38 IST
How cancer becomes drug-resistant, find researchers

New York: A team of researchers, including an Indian-American scientist, has found that the major reason cancer drugs fail is that they cannot penetrate the high-pressure environment of solid tumours.

The findings revealed that hyaluronic acid – a large, naturally occurring molecule – is primarily responsible for generating elevated gel-fluid pressures in tumours.

How cancer becomes drugresistant find researchers

Representational imgae. Reuters

"We show that the gel-fluid phase generates a primary mechanism of drug resistance in pancreas cancer," said lead researcher Sunil Hingorani from the Fred Hutchinson Cancer Research Center in the US.

A hyaluronidase treatment – family of enzymes that degrade hyaluronic acid – holds promise for improving patient outcomes for drug-resistant cancers.

In the study, published in Biophysical Journal, the team conducted hyaluronidase treatment in a mouse model of pancreatic cancer and found that it broke down hyaluronic acid as well as normalised the fluid pressure in tumours, allowing vessels to re-expand and thereby overcoming a major barrier to drug delivery.

This treatment eliminated the immobile fluid phase and allowed vessels that had collapsed under pressure to re-expand.

Preliminary results have shown that this treatment significantly improves response rates and progression-free survival in pancreatic cancer patients.

Using an instrument called piezoelectric pressure catheter transducer, the team captured both free- and immobile-fluid pressures in tumours.

The measurements of fluid pressure using the new instrument were much higher.

Moreover, elevated fluid pressures measured by the instrument correlated with high levels of hyaluronic acid in a variety of tumour models.

"The findings show that the hyaluronic acid-dependent immobile fluid phase plays a previously underappreciated role in driving high pressures in solid tumours," Hingorani added.

The researchers plan to further examine the mechanisms behind high immobile fluid pressures in solid tumours.

"Similarly, elevated pressures due to a gel-fluid phase may be present in many other solid tumour types, so it may be worth seeing to what extent drug delivery can be improved in those settings as well," Hingorani noted.

Updated Date:

also read

COVID-19 Delta variant expected to become dominant strain in coming months, says WHO
World

COVID-19 Delta variant expected to become dominant strain in coming months, says WHO

The organisation said overall 3.4 million new COVID-19 cases were reported in the week to 18 July, which is a 12 percent increase from the week before

Goa follows Centre's footsteps, says no patient deaths due to oxygen shortage
India

Goa follows Centre's footsteps, says no patient deaths due to oxygen shortage

Earlier the Goa health minister had said on 11 May that 26 persons had died within 24 hours at the GMCH due to oxygen shortage.

Tokyo Olympics 2020: Rory McIlroy '100 percent' supports Simone Biles' Olympic withdrawal over mental well-being
Sports

Tokyo Olympics 2020: Rory McIlroy '100 percent' supports Simone Biles' Olympic withdrawal over mental well-being

US star Biles, one of the faces of the Tokyo Olympics, abruptly withdrew from the team final on Tuesday before scratching from Thursday's all-around final over concerns for her mental well-being.